SenoRx names Buhler CEO
This article was originally published in The Gray Sheet
Executive Summary
Breast cancer device maker appoints John T. Buhler CEO, effective immediately, the firm announces March 16. Buhler, formerly president and chief operating officer, had been acting CEO since former CEO Lloyd H. Malchow went on medical leave in February (1"The Gray Sheet" Feb. 22, 2010). Malchow passed away on March 14